Vytrus Biotech, S.A. (BME:VYT)
Spain flag Spain · Delayed Price · Currency is EUR
13.15
-0.05 (-0.38%)
Last updated: Nov 13, 2026, 1:21 PM CET

Vytrus Biotech Revenue

Vytrus Biotech had revenue of 6.00M EUR in the half year ending June 30, 2026, with 139.84% growth. This brings the company's total for the last twelve months to 10.00M, up 44.45% year-over-year. In the year 2025, Vytrus Biotech had annual revenue of 8.37M with 65.95% growth. That makes Vytrus Biotech the 36,944th largest company in the world by revenue and 167th in Spain.

Revenue (ttm)
10.00M
Revenue Growth
+44.45%
P/S Ratio
9.90
Revenue / Employee
212.70K
Employees
47
Market Cap
98.94M

Revenue Chart

Revenue by Geography

  • Export 3.17M 37.8%
  • European Union 2.62M 31.3%
  • Spain 2.59M 30.9%
Fiscal year ended Dec 31, 2025 See the full Vytrus Biotech breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20258.37M3.33M65.95%
Dec 31, 20245.04M1.31M35.00%
Dec 31, 20233.74M54.51K1.48%
Dec 31, 20223.68M877.98K31.31%
Dec 31, 20212.80M1.10M64.49%
Dec 31, 20201.70M482.98K39.53%
Dec 31, 20191.22M334.11K37.63%
Dec 31, 2018887.81K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.